Viewing nowCombinationLina Empa Tablet 10/5 mg (Empagliflozin, Linagliptin)
Linagliptin Micronized 5mg · Empagliflozin 10mg
Tablet · Prescription medication · Combination
Green Cross Corporation

MFDS item code 202402282 · Approved 2024.09.23
Improvement of blood glucose control in patients with type 2 diabetes mellitus
This medication is used to help control blood sugar levels in patients with type 2 diabetes by administering empagliflozin and linagliptin together. When taken alongside diet and exercise, it can effectively manage blood sugar levels. This leads to improved blood sugar control ability and a smoother management of diabetes for patients.
The recommended starting dose of this medicine is empagliflozin 10 mg/linagliptin 5 mg once daily. If additional glycemic control is needed and empagliflozin 10 mg/linagliptin 5 mg is well tolerated, the dose of this medicine may be increased to 25/5 mg once daily. Patients switching to this medicine from concomitant empagliflozin and linagliptin therapy should receive their previous doses. This medicine may be taken with or without food. Swallow the tablet whole. If a dose of this medicine is missed, take it as soon as remembered. However, if the next dose is due within 12 hours, skip the missed dose and resume the usual dosing schedule. Do not take a double dose in one day. Patients with renal impairment: This medicine is not recommended to improve glycemic control in patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2. No dose adjustment is necessary in patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. Elderly patients: No dose adjustment based on age is necessary. In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.
This medication is a diabetes treatment containing both empagliflozin and linagliptin as ingredients. First, this medication should not be used by individuals allergic to empagliflozin, linagliptin, or any other ingredient contained in the drug, by patients with type 1 diabetes, diabetic ketoacidosis, or those undergoing kidney dialysis. Patients with impaired kidney function should regularly undergo kidney function tests before taking this medication. It is especially important to check kidney status at least once a year before starting the medication and during treatment. For patients with mild symptoms of heart failure, careful use is advised, while it is not recommended for patients with severe heart failure. While taking this medication, there is a risk of developing acute pancreatitis, so if symptoms such as abdominal pain or vomiting occur, prompt consultation with a physician is necessary. Additionally, a rare skin condition called bullous pemphigoid that causes blisters may occur, and any skin abnormalities should be reported immediately. The most common side effect is urinary tract infection, but other possible side effects include hypoglycemia, thirst, cough, constipation, itching, and rash. Particular caution is needed if this medication is taken alongside other blood sugar-lowering agents such as insulin or sulfonylureas due to the increased risk of hypoglycemia. Also, this medication may reduce the body's fluid levels, so elderly patients or those with cardiovascular disease who are at risk of dehydration or low blood pressure should exercise caution when taking it. Care is also needed while driving or operating machinery to reduce the risk of accidents due to hypoglycemia. Pregnant or breastfeeding women are advised to avoid taking this medication, especially during breastfeeding as it may transfer to the baby through breast milk, and discontinuing breastfeeding is recommended. Lastly, this medication is not recommended for use in children under 18 years old, as safety and efficacy have not been established. If any abnormal symptoms occur while taking this medication, immediate consultation with healthcare professionals is important, and regular check-ups to manage health status are crucial.
Not everyone experiences these, and they can vary from person to person.
This medication should be kept in a tightly sealed container to prevent exposure to air or moisture, and it is safe to store at room temperature between 1 and 30 degrees Celsius. Therefore, it is important to store it in an appropriate temperature and environment to maintain the medication's effectiveness.
Pale yellow circular film-coated tablet
PTP - 30 tablets/box [10 tablets/PTP x 3], bottle - 30 tablets/bottle, bottle - 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationLinagliptin Micronized 5mg · Empagliflozin 10mg
Tablet · Prescription medication · Combination
Green Cross Corporation
CombinationLinagliptin Micronized 5mg · Empagliflozin 25mg
Tablet · Prescription medication · Combination
(Co., Ltd.) Green Cross
CombinationEmpagliflozin 10mg · Linagliptin Micronized 5mg
Tablet · Prescription medication · Combination
Medica Korea Co., Ltd.
CombinationEmpagliflozin 25mg · Linagliptin Micronized 5mg
Tablet · Prescription medication · Combination
Medica Korea Co., Ltd.
Empagliflozin 10mg · Linagliptin Micronized 5mg
Tablet · Prescription medication · Combination
Cheil Pharmaceutical Co., Ltd.
Empagliflozin 25mg · Linagliptin Micronized 5mg
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.